Stefan de Vogel

1.1k total citations
23 papers, 676 citations indexed

About

Stefan de Vogel is a scholar working on Rheumatology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Stefan de Vogel has authored 23 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 6 papers in Molecular Biology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Stefan de Vogel's work include Folate and B Vitamins Research (8 papers), Epigenetics and DNA Methylation (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Stefan de Vogel is often cited by papers focused on Folate and B Vitamins Research (8 papers), Epigenetics and DNA Methylation (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Stefan de Vogel collaborates with scholars based in Netherlands, United States and Norway. Stefan de Vogel's co-authors include Piet A. van den Brandt, Matty P. Weijenberg, Manon van Engeland, R. Alexandra Goldbohm, Adriaan P. de Bruı̈ne, Kristien Wouters, Anton F.P.M. de Goeij, Per Magne Ueland, Ralph W.H. Gottschalk and Frederik‐Jan van Schooten and has published in prestigious journals such as The Lancet, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Stefan de Vogel

23 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefan de Vogel Netherlands 14 211 191 148 110 101 23 676
Evangelia Kaklamani Greece 14 200 0.9× 183 1.0× 62 0.4× 160 1.5× 73 0.7× 18 1.1k
A. Obrador Spain 14 122 0.6× 176 0.9× 267 1.8× 356 3.2× 76 0.8× 39 1.0k
Ting‐Yuan David Cheng United States 16 204 1.0× 105 0.5× 121 0.8× 236 2.1× 132 1.3× 61 788
Yoon-Ok Ahn South Korea 11 148 0.7× 53 0.3× 194 1.3× 157 1.4× 48 0.5× 13 764
Daphne Chan Canada 20 112 0.5× 200 1.0× 81 0.5× 75 0.7× 29 0.3× 47 1.6k
Patricia Sorroche Argentina 16 101 0.5× 99 0.5× 45 0.3× 46 0.4× 56 0.6× 58 626
NJ Wald United Kingdom 9 154 0.7× 220 1.2× 179 1.2× 45 0.4× 61 0.6× 15 765
W.-P. Koh Singapore 11 77 0.4× 64 0.3× 143 1.0× 111 1.0× 49 0.5× 13 598
Maarten T.M. Raijmakers Netherlands 20 246 1.2× 175 0.9× 210 1.4× 61 0.6× 54 0.5× 51 1.5k
Tzeon‐Jye Chiou Taiwan 17 245 1.2× 71 0.4× 97 0.7× 254 2.3× 45 0.4× 66 958

Countries citing papers authored by Stefan de Vogel

Since Specialization
Citations

This map shows the geographic impact of Stefan de Vogel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan de Vogel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan de Vogel more than expected).

Fields of papers citing papers by Stefan de Vogel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan de Vogel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan de Vogel. The network helps show where Stefan de Vogel may publish in the future.

Co-authorship network of co-authors of Stefan de Vogel

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan de Vogel. A scholar is included among the top collaborators of Stefan de Vogel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan de Vogel. Stefan de Vogel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Phiri, Kelesitse, Jesper Hallas, Marie Linder, et al.. (2021). A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder. Current Medical Research and Opinion. 37(5). 867–877. 2 indexed citations
2.
Arana, Alejandro, Andrea V. Margulis, Cristina Varas‐Lorenzo, et al.. (2020). Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom. Pharmacoepidemiology and Drug Safety. 30(2). 237–247. 12 indexed citations
3.
Heintjes, Edith M., Irene D. Bezemer, Daniel Prieto‐Alhambra, et al.. (2020). <p>Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries</p>. Clinical Epidemiology. Volume 12. 423–433. 3 indexed citations
4.
Nygård, Ottar, Stefan de Vogel, Gard Frodahl Tveitevåg Svingen, et al.. (2018). Plasma 25-Hydroxyvitamin D and Mortality in Patients With Suspected Stable Angina Pectoris. The Journal of Clinical Endocrinology & Metabolism. 103(3). 1161–1170. 15 indexed citations
5.
Margulis, Andrea V., Joan Fortuny, James A. Kaye, et al.. (2017). Validation of Cancer Cases Using Primary Care, Cancer Registry, and Hospitalization Data in the United Kingdom. Epidemiology. 29(2). 308–313. 52 indexed citations
6.
Reulen, Raoul C., Stefan de Vogel, Weide Zhong, et al.. (2017). Physical activity and risk of prostate and bladder cancer in China: The South and East China case-control study on prostate and bladder cancer. PLoS ONE. 12(6). e0178613–e0178613. 15 indexed citations
7.
Braun, Armin, Susanne N. Kolle, Robert Landsiedel, et al.. (2016). Prevalidation of the ex-vivo model PCLS for prediction of respiratory toxicity. Toxicology in Vitro. 32. 347–361. 31 indexed citations
8.
Vogel, Stefan de, Kerstin B. Meyer, Åshild Fredriksen, et al.. (2013). Serum folate and vitamin B12 concentrations in relation to prostate cancer risk--a Norwegian population-based nested case-control study of 3000 cases and 3000 controls within the JANUS cohort. International Journal of Epidemiology. 42(1). 201–210. 35 indexed citations
9.
Vogel, Stefan de, Arve Ulvik, Klaus Meyer, et al.. (2013). Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer—A large nested case–control study within the JANUS cohort in Norway. International Journal of Cancer. 134(1). 197–206. 45 indexed citations
10.
Vogel, Stefan de, et al.. (2012). Pre-validation of the PCLS Ex Vivo Model for the Prediction of Respiratory Toxicology. 1 indexed citations
11.
Vogel, Stefan de, Jørn Schneede, Per Magne Ueland, et al.. (2011). Biomarkers Related to One-Carbon Metabolism as Potential Risk Factors for Distal Colorectal Adenomas. Cancer Epidemiology Biomarkers & Prevention. 20(8). 1726–1735. 30 indexed citations
12.
Vogel, Stefan de, Kristien Wouters, Ralph W.H. Gottschalk, et al.. (2010). Dietary methyl donors, methyl metabolizing enzymes, and epigenetic regulators: diet–gene interactions and promoter CpG island hypermethylation in colorectal cancer. Cancer Causes & Control. 22(1). 1–12. 31 indexed citations
13.
Vogel, Stefan de, Kristien Wouters, Ralph W.H. Gottschalk, et al.. (2009). Genetic Variants of Methyl Metabolizing Enzymes and Epigenetic Regulators: Associations with Promoter CpG Island Hypermethylation in Colorectal Cancer. Cancer Epidemiology Biomarkers & Prevention. 18(11). 3086–3096. 77 indexed citations
14.
Vogel, Stefan de, et al.. (2008). Dietary Folate, Methionine, Riboflavin, and Vitamin B-6 and Risk of Sporadic Colorectal Cancer. Journal of Nutrition. 138(12). 2372–2378. 84 indexed citations
15.
Vogel, Stefan de, Brenda Bongaerts, Kristien Wouters, et al.. (2008). Associations of dietary methyl donor intake with MLH1 promoter hypermethylation and related molecular phenotypes in sporadic colorectal cancer. Carcinogenesis. 29(9). 1765–1773. 81 indexed citations
16.
Bongaerts, Brenda, Anton F.P.M. de Goeij, Stefan de Vogel, et al.. (2007). Alcohol consumption and distinct molecular pathways to colorectal cancer. British Journal Of Nutrition. 97(3). 430–434. 12 indexed citations
17.
Vogel, Stefan de, Manon van Engeland, Margreet Lüchtenborg, et al.. (2006). Dietary Folate and APC Mutations in Sporadic Colorectal Cancer. Journal of Nutrition. 136(12). 3015–3021. 22 indexed citations
18.
Hoorn, Ewout J., Stefan de Vogel, & Robert Zietse. (2005). Insulin resistance in an 18‐year‐old patient with Down syndrome presenting with hyperglycaemic coma, hypernatraemia and rhabdomyolysis. Journal of Internal Medicine. 258(3). 285–288. 6 indexed citations
19.
Verhoef, Hans, Clive E. West, Stefan de Vogel, et al.. (2002). Intermittent administration of iron and sulfadoxine-pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. The Lancet. 360(9337). 908–914. 85 indexed citations
20.
Grant, Cameron, Ashalata Pati, Tan Ding, et al.. (2001). Ethnic comparisons of disease severity in children hospitalized with pneumonia in New Zealand. Journal of Paediatrics and Child Health. 37(1). 32–37. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026